Answers are grounded in this paper and cite their sources.
BACKGROUND: Hemorrhagic shock leads to the appearance of substances in plasma that can change Na/K ATPase activity. Our laboratory has reported the existence of a plasma inhibitor of Na/K ATPase that appears during shock. Recently, we have isolated a substance in plasma that stimulates Na/K ATPase. METHODS: Using liquid chromatography, we found a fraction of plasma that simulated Na/K ATPase. The purified substance was identified as adenosine by its UV spectrum. Na/K ATPase activity was assessed using 86Rb uptake in erythrocytes. RESULTS: Plasma from rat, dog, and calf stimulated Na/K ATPase activity in a dose-dependent manner and this stimulation was inhibited by ouabain. Commercial adenosine also stimulated Na/K ATPase in a dose-dependent manner and was inhibited by ouabain. Na/K ATPase was not stimulated by ATP, ADP, AMP adenine, hypoxanthine, xanthine or uric acid. Stimulation by adenosine (1 mmol/L) was not affected by adenosine receptor antagonists, caffeine (1 mmol/L) or aminophylline (1 mmol/L). However, the stimulation was inhibited by the nucleoside transport blocker, dipyridamole, suggesting that adenosine acts inside the cell. Adenosine (0.5 mmol/L) given to rats in hemorrhagic shock survived longer suggesting that stimulation of Na/K ATPase prolongs survival during hemorrhagic shock. CONCLUSION: Adenosine stimulates Na/K ATPase and prolongs survival in hemorrhagic shock, possible by reversing or overcoming the effects of an endogenous inhibitor of Na/K ATPase, as it does for ouabain. The effect of adenosine on Na/K ATPase is not mediated through adenosine receptors and probably results from an intracellular process.
No takes yet. Share an insight, caveat, or question.
Darlington et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: